LIVE PULSE
3.9 Anthropic CEO Amodei calls for slower AI development and shared safety rules — 11 src2.1 Agility Robotics unveils Digit 5 humanoid for warehouses and factories — 2 src2.0 Apple ships rebuilt Siri with Google Gemini, but not in the EU — 2 src1.7 Siri AI in macOS 27 Golden Gate: FAQ, Germany availability, privacy questions — 2 src1.4 Sam Altman says OpenAI will not go public in 2026, citing AI safety concerns — 5 src1.1 OpenAI contractors review real ChatGPT conversations to rate responses, report says — 2 src1.1 Anthropic data retention policy prompts firms to limit Claude use for sensitive work — 1 src1.1 Study examines issue bias in LLMs used as writing assistants before Swedish 2026 election — 1 src1.1 Study Audits Misalignment in Multi-Modal World Models — 1 src1.1 Retrieval-Grounded Reasoning Approach Proposed for Universal Multimodal Embeddings — 1 src3.9 Anthropic CEO Amodei calls for slower AI development and shared safety rules — 11 src2.1 Agility Robotics unveils Digit 5 humanoid for warehouses and factories — 2 src2.0 Apple ships rebuilt Siri with Google Gemini, but not in the EU — 2 src1.7 Siri AI in macOS 27 Golden Gate: FAQ, Germany availability, privacy questions — 2 src1.4 Sam Altman says OpenAI will not go public in 2026, citing AI safety concerns — 5 src1.1 OpenAI contractors review real ChatGPT conversations to rate responses, report says — 2 src1.1 Anthropic data retention policy prompts firms to limit Claude use for sensitive work — 1 src1.1 Study examines issue bias in LLMs used as writing assistants before Swedish 2026 election — 1 src1.1 Study Audits Misalignment in Multi-Modal World Models — 1 src1.1 Retrieval-Grounded Reasoning Approach Proposed for Universal Multimodal Embeddings — 1 src
HEATPULSEAI MAGAZINES
FLIP · FOLLOW · SAVE
Log inSign up

breast-cancer

topic2 events
papersTODAY 04:00 UTC

Causal multi-modal AI model predicts chemotherapy sensitivity in breast cancer

A new arXiv preprint describes a causal, multi-modal AI approach for predicting which breast cancer patients will benefit from chemotherapy. The authors argue that current reliance on recurrence scores as a stand-in for treatment benefit may drive unnecessary chemotherapy use. Their method aims to give clinicians a more personalized estimate of chemosensitivity.

medical-ai/multi-modal/causal-inference/breast-cancer
papersTODAY 04:00 UTC

Edge AI Medical Device System Tested for Breast Cancer Team Meetings

Researchers present a system that runs AI models locally on edge hardware as a regulated medical device, aimed at supporting breast cancer multidisciplinary team meetings. The paper reports a feasibility evaluation, noting that existing AI-supported workflows for these meetings depend on cloud infrastructure. The work targets reducing documentation burden and time pressure in complex case reviews.

medical-ai/edge-ai/healthcare/research